Cell Marque1次抗体

                                       製造元:Cell Marque

 

GATA3(L50-823)

GATA3 expression is primarily seen in breast carcinoma.  GATA3 is expressed in ALL lobular breast carcinomas and in a high percentage of invasive ductal carcinomas.  GATA3 is negative in lung and thyroid carcinomas.  It has been reported in literature that GATA3 expression is correlated with the status of ER, PR, and Her2/Neu in breast carcinoma.  Another important application for GATA3 is in the expression in urothelial carcinomas.  It is especially expressive in invasive and high grade tumors, and it is negative in prostate and renal cell carcinomas.  Unlike other markers that have similar applications, GATA3 has a nuclear visualization.

コントロール:Breast carcinoma, urothelial carcinoma

CMQ 390M-14

GATA3 (L50-823) 抗体

0.1mL

 

1:100-1:500*

CMQ 390M-15

GATA3 (L50-823) 抗体

0.5mL

 

1:100-1:500*

CMQ 390M-16

GATA3 (L50-823) 抗体

1mL

 

1:100-1:500*

CMQ 390M-17

GATA3 (L50-823) 抗体

1mL

 

 

CMQ 390M-18

GATA3 (L50-823) 抗体

7mL

 

 

CMQ 390S

GATA3 コントロールスライド

5スライド

 

 

 

Caveolin-1 (2297)

Caveolin-1 is useful in differentiating epithelioid mesothelioma from lung adenocarcinoma. Caveolin-1 is positive for mesothelioma and negative for lung adenocarcinoma which is why this marker should be used in lung panels in conjunction with napsin A, TTF-1, CEA, and Ber-EP4.  Caveolin-1 is comparable to, and in some cases even superior to, other established markers for mesothelioma such as podoplanin, calretinin, HBME-1, and WT1.

 コントロール:Mesothelioma, Ewing sarcoma

CMQ 412M-14

Caveolin-1 (2297) 抗体

0.1mL

 

1:25-1:100*

CMQ 412M-15

Caveolin-1 (2297) 抗体

0.5mL

 

1:25-1:100*

CMQ 412M-16

Caveolin-1 (2297) 抗体

1mL

 

1:25-1:100*

CMQ 412M-17

Caveolin-1 (2297) 抗体

1mL

 

 

CMQ 412M-18

Caveolin-1 (2297) 抗体

7mL

 

 

CMQ 412S

Caveolin-1 コントロールスライド

5スライド

 

 

  

Thyroid Peroxidase (EP159)

Thyroid Peroxidase (TPO) is a useful marker for identifying thyroid carcinoma.  When used in a panel with HBME-1, galectin-3 and cytokeratin 19, TPO can help with the identification of thyroid carcinoma of the papillary and follicular types.  TPO is also useful in differentiating metastatic thyroid carcinoma from other carcinomas, especially lung adenocarcinoma.

 コントロール:Thyroid, papillary thyroid carcinoma

CMQ 409R-14

Thyroid Peroxidase (EP159) 抗体

0.1mL

 

1:25-1:100*

CMQ 409R-15

Thyroid Peroxidase (EP159) 抗体

0.5mL

 

1:25-1:100*

CMQ 409R-16

Thyroid Peroxidase (EP159) 抗体

1mL

 

1:25-1:100*

CMQ 409R-17

Thyroid Peroxidase (EP159) 抗体

1mL

 

 

CMQ 409R-18

Thyroid Peroxidase (EP159) 抗体

7mL

 

 

CMQ 409S

Thyroid Peroxidase コントロールスライド

5スライド

 

 

 

Treponema pallidum (polyclonal)

Treponema pallidum, commonly known as "spirochete," is identified as T. pallidum infection in the second stage of the disease syphilis. In the first stage of syphilis, the inflammatory stage, the plasma cells inflame making the disease undetectable. When syphilis progresses to stage two, it begins to attack the organs associated with the immune system (skin, liver, spleen, etc.). It is here that T. pallidum IHC is useful because it helps detect the presence of the small microorganisms more accurately than other methods, such as special stains and serological assays.1,2 When included with a panel of other infectious disease markers, spirochete (T. pallidum) will only be expressed in syphilis, making this marker imperative for the identification of this disease.

CMQ 397A-14

Treponema pallidum 抗体

0.1mL

 

-

CMQ 397A-15

Treponema pallidum 抗体

0.5mL

 

-

CMQ 397A-16

Treponema pallidum 抗体

1mL

 

-

CMQ 397A-17

Treponema pallidum 抗体

1mL

 

 

CMQ 397A-18

Treponema pallidum 抗体

7mL

 

 

CMQ 397S

Treponema pallidum コントロールスライド

5スライド

 

 

 

Heat Shock Protein 27 (G3.1)

Heat shock protein 27 (HSP27) is useful in the identification of high-grade dysplasia and cervical squamous cell carcinoma.  A well-known cervical marker, p16, stains both high and low-grade dysplasia.  It has been reported that HSP27 is expressed in a higher percentage of cervical squamous cell carcinomas than p16 (Tozawa-Ono A, et al. Human Cell 2012; 25:24–28). HSP27 is recommended as a complementary antibody to p16 for routine cervical dysplasia and cervical cancer testing.

コントロール:Cervical intraepithelial neoplasm, cervical squamous cell carcinoma

CMQ 398M-14

Heat Shock Protein 27 (G3.1) 抗体

0.1mL

 

1:25-1:100*

CMQ 398M-15

Heat Shock Protein 27 (G3.1) 抗体

0.5mL

 

1:25-1:100*

CMQ 398M-16

Heat Shock Protein 27 (G3.1) 抗体

1mL

 

1:25-1:100*

CMQ 398M-17

Heat Shock Protein 27 (G3.1) 抗体

1mL

 

 

CMQ 398M-18

Heat Shock Protein 27 (G3.1) 抗体

7mL

 

 

CMQ 398S

Heat Shock Protein 27 コントロールスライド

5スライド

 

 

 

Cytokeratin (CAM 5.2)

Cytokeratin (CAM 5.2) is the most widely recognized low molecular weight keratin. CAM 5.2 is a marker that can be used in the identification of hepatocellular neoplasms, which are negative for Cytokeratin Cocktail (AE1/AE3), as well as for lymph node metastases in breast cancer and lung cancer.  It can also be used to stain simple epithelia. 

コントロール:Hepatocellular carcinoma, appendix

CMQ 452M-94

Cytokeratin (CAM 5.2) 抗体

0.1mL

 

1:25-1:100*

CMQ 452M-95

Cytokeratin (CAM 5.2) 抗体

0.5mL

 

1:25-1:100*

CMQ 452M-96

Cytokeratin (CAM 5.2) 抗体

1mL

 

1:25-1:100*

CMQ 452M-97

Cytokeratin (CAM 5.2) 抗体

1mL

 

 

CMQ 452M-98

Cytokeratin (CAM 5.2) 抗体

7mL

 

 

CMQ 452M-90

Cytokeratin (CAM 5.2) 抗体

25mL

 

 

 

Cytokeratin 10 (EP97)

Cytokeratin 10 is used in the identification of squamous cell carcinomas.  It is present in all suprabasal epithelial cells (stratified epithelium).  Squamous cell carcinoma can arise from any type of stratified epithelium.  Cytokeratin 10 can then help differentiate squamous cell carcinomas from non-squamous cell carcinomas. 

コントロール:Squamous cell carcinoma

CMQ 410R-14 Cytokeratin 10 (EP97) 抗体

0.1mL

 

1:25-1:100*

CMQ 410R-15 Cytokeratin 10 (EP97) 抗体

0.5mL

 

1:25-1:100*

CMQ 410R-16 Cytokeratin 10 (EP97) 抗体

1mL

 

1:25-1:100*

CMQ 410R-17 Cytokeratin 10 (EP97) 抗体

1mL

 

 

CMQ 410R-18 Cytokeratin 10 (EP97) 抗体

7mL

 

 

CMQ 410S Cytokeratin 10 コントロールスライド

25mL

 

 

 

 S100A1 (EP184)

S100A1 is used in identifying renal oncocytoma.  S100A1 differentiates renal oncocytoma from chromophobe renal cell carcinoma of the kidney.  Combined with other IHC markers such as parvalbumin, CD117, Ksp-cadherin, and vimentin, S100A1 can be very useful in subtyping renal cell carcinoma.

コントロール:Renal oncocytoma, kidney

CMQ 408R-14

S100A1 (EP184) 抗体

0.1mL

 

1:25-1:100*

CMQ 408R-15

S100A1 (EP184) 抗体

0.5mL

 

1:25-1:100*

CMQ 408R-16

S100A1 (EP184) 抗体

1mL

 

1:25-1:100*

CMQ 408R-17

S100A1 (EP184) 抗体

1mL

 

 

CMQ 408R-18

S100A1 (EP184) 抗体

7mL

 

 

CMQ 408S

S100A1 コントロールスライド

5スライド

 

 

 

Other products

品名

品番

品名

品番

Cadherin-17(SP183)

CMQ 378R-1418

CD13(SP187)

CMQ 113R-1418

CD16(SP175)

CMQ 116R-1418

Nestin(10C2)

CMQ 388M-1418

Olig2(211F1.1)

CMQ 387M-1418

SALL4(6E3)

CMQ 385M-1418

Adipophilin(poly)

CMQ 393A-1418

c-myc(EP121)

CMQ 395R-1418

Langerin(12D6)

CMQ 392M-1418

Parvalbumin(2E11)

CMQ 396M-1418

Stathmin(SP49)

CMQ 394R-1418

TIA-1(EP243)

CMQ 381R-1418